title: Daytime sleepiness in elderly Parkinson's disease patients and treatment with the psychostimulant modafinil: A preliminary study.
abstract: BACKGROUND
  Patients with Parkinson's disease (PD) or Parkinsonian syndromes often report excessive daytime sleepiness (EDS). The aim of this study was to evaluate the effects of the psychostimulant modafinil on elderly, institutionalized, severely impaired PD patients with EDS.
  
  
  METHODS
  A three-week open study on ten institutionalized PD patients scoring >10 points on the Epworth Sleepiness Scale (ESS) with modafinil eventually on 100 mg twice a day. Patients were assessed at the start, week 1, and week 3 with ESS, Clinical Global Impression (CGI) scale severity of PD and appetite.
  
  
  RESULTS
  Reduction of ESS score and PD severity over time were found as well as a significant increase in appetite and reduction in CGI score.
  
  
  CONCLUSIONS
  Modafinil 100 mg twice a day was safe and modestly effective for the treatment of EDS in elderly, institutionalized PD patients. Sustaining wakefulness throughout all stages of PD is crucial for participating in life, maintaining social life, and improving quality of life.
authors.affiliation: Institution of Neurobiology, Caring Sciences, and Society, Karolinska Institute, Stockholm, Sweden. johan.lokk@karolinska.se
authors.forename: Johan
authors.initials: J
authors.lastname: Lökk
references.citation: Mov Disord. 2005 Jul;20(7):832-42
references.pmid: 15726539
references.citation: J Opioid Manag. 2006 May-Jun;2(3):130-6
references.pmid: 17319446
references.citation: Clin Chest Med. 1998 Mar;19(1):169-81
references.pmid: 9554226
references.citation: Expert Opin Drug Saf. 2007 Sep;6(5):533-45
references.pmid: 17877441
references.citation: Aging Clin Exp Res. 2007 Oct;19(5):349-55
references.pmid: 18007112
references.citation: Sleep. 1991 Dec;14(6):540-5
references.pmid: 1798888
references.citation: JAMA. 2002 Jan 23-30;287(4):455-63
references.pmid: 11798367
references.citation: Neurology. 2002 May 28;58(10):1544-6
references.pmid: 12034797
references.citation: Int Psychogeriatr. 1996 Summer;8(2):277-88; discussion 288-90
references.pmid: 8994897
references.citation: Am J Nurs. 2007 May;107(5):40-9; quiz 50
references.pmid: 17443076
references.citation: J Clin Neurosci. 2007 Jan;14(1):33-40
references.pmid: 17138067
references.citation: CNS Spectr. 2007 Feb;12(2 Suppl 2):1-14; quiz 15
references.pmid: 17277717
references.citation: Sleep Med Rev. 2005 Jun;9(3):185-200
references.pmid: 15893249
references.citation: Brain Res. 2008 Jan 16;1189:219-28
references.pmid: 18076869
references.citation: Neuropsychiatr Dis Treat. 2009;5:535-40
references.pmid: 19898667
references.citation: J Neurol. 2007 Aug;254(8):1037-43
references.pmid: 17351722
references.citation: Psychiatry Clin Neurosci. 1998 Apr;52(2):190-2
references.pmid: 9628145
references.citation: Psychiatry Clin Neurosci. 1999 Apr;53(2):273-5
references.pmid: 10459710
references.citation: J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
references.pmid: 1564476
references.citation: Clin Pharmacokinet. 2003;42(2):123-37
references.pmid: 12537513
references.citation: Sleep. 1994 Aug;17(5):436-7
references.pmid: 7991954
references.citation: J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1636-9
references.pmid: 16291885
references.citation: Sleep. 2002 Dec;25(8):905-9
references.pmid: 12489899
references.citation: Clin Neuropharmacol. 2002 Mar-Apr;25(2):111-4
references.pmid: 11981239
references.citation: Adv Neurol. 2003;91:329-34
references.pmid: 12442690
references.citation: Curr Neurol Neurosci Rep. 2006 Mar;6(2):169-76
references.pmid: 16522272
references.citation: J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1117-21
references.pmid: 18682443
references.citation: Mov Disord. 2003 Mar;18(3):287-93
references.pmid: 12621632
references.citation: Sleep Breath. 2001 Dec;5(4):181-91
references.pmid: 11868158